- Joined
- Apr 24, 2002
- Messages
- 43,155
- Reaction score
- 92
Just got this via my email:
Link
Wednesday, June 21, 2006
National Politics & Policy
Brownback Holds News Conference To Highlight Successes of Adult, Umbilical Cord Stem Cells
Sen. Sam Brownback (R-Kan.) on Tuesday held a news conference on Capitol Hill to highlight the contrast between medical successes of treatments from adult and umbilical cord stem cells -- which do not involve the destruction of human embryos -- and the "speculative" prospects for treatments derived from human embryonic stem cell research, CQ HealthBeat reports. Brownback said the 70th peer-reviewed publication showing a medical success from adult stem cells or stem cells from umbilical cord blood will be published this week, and he brought people who had received such treatments to speak at the conference. Brownback said it is important for umbilical cord blood to be stored and for adult stem cell treatment barriers to be lowered so that people do not have to travel outside of the U.S. to receive stem cell treatments. According to CQ HealthBeat, the press conference "countered" one recently held by senators who support embryonic stem cell research (Reichard, CQ HealthBeat, 6/20). Reps. Michael Castle (R-Del.) and Diana DeGette (D-Colo.) and Sens. Dianne Feinstein (D-Calif.), Tom Harkin (D-Iowa), Orrin Hatch (R-Utah), Edward Kennedy (D-Mass.), Gordon Smith (R-Ore.) and Arlen Specter (R-Pa.) last month participated in a conference organized by the Coalition for the Advancement of Medical Research calling on Senate Majority Leader Bill Frist (R-Tenn.) to bring to a vote a measure (HR 810, S 471) that would allow federal funding for research using stem cells derived from embryos originally created for fertility treatments and willingly donated by patients. Frist last month said he plans to schedule debate this summer on three separate bills involving stem cell research, but he did not stipulate which measures would be discussed. Other pending stem cell measures include a proposal (S 658) sponsored by Brownback that would prohibit human cloning for research and reproductive purposes, legislation (S 2754) introduced by Sens. Rick Santorum (R-Pa.) and Specter that would provide funding for NIH to research and create ways to retrieve pluripotent stem cells -- which, like embryonic stem cells, can produce all types of tissues in the body -- without destroying embryos; and a bill (S 1520) sponsored by Feinstein that would ban human cloning for reproductive purposes but not for therapeutic or research reasons (Kaiser Daily Women's Health Policy Report, 5/24).
Forum Participants Discuss Santorum, Specter Bill
In related news, advocates and opponents of embryonic stem cell research on Monday at a forum on Capitol Hill discussed the Santorum and Specter bill, CQ Healthbeat reports. Some researchers, such as Stanford University biochemist William Hurlbut, say that alternative methods to deriving pluripotent stem cells, such as altered nuclear transfer, also could advance the research without causing a moral debate, CQ HealthBeat reports (CQ HealthBeat, 6/19). Altered nuclear transfer involves implanting DNA from a donor's cell into a human egg that has had its nucleus removed and then stimulating the egg to divide. With this technique, scientists could prevent cells from organizing into a human embryo and still harvest embryonic stem cells, according to Hurlbut (Kaiser Daily Women's Health Policy Report, 2/14). However, W. Malcolm Byrnes, a Howard University College of Medicine biochemistry professor, and Catholic University of America professor Jose Granados in a paper wrote that altered nuclear transfer goes through stages that are "indistinguishable from those of a normal embryo," adding, "Could we not say, then, that we have created a defective embryo that is from the outset prevented from developing fully?" In addition, Paul Schenck, director of the National Pro-Life Action Center, said that a Senate vote to fund the measure would "set up a slippery slope and be morally bankrupt ... [and] would be an act of gross negligence." However, Richard Doerflinger, deputy director of the secretariat for pro-life activities at the United States Conference of Catholic Bishops, said the bill promotes only methods of deriving pluripotent stem cells that do not destroy a human embryo, and if a method such as altered nuclear transfer created a defective embryo, it would not be permitted under the measure (CQ HealthBeat, 6/19).
Link
Wednesday, June 21, 2006
National Politics & Policy
Brownback Holds News Conference To Highlight Successes of Adult, Umbilical Cord Stem Cells
Sen. Sam Brownback (R-Kan.) on Tuesday held a news conference on Capitol Hill to highlight the contrast between medical successes of treatments from adult and umbilical cord stem cells -- which do not involve the destruction of human embryos -- and the "speculative" prospects for treatments derived from human embryonic stem cell research, CQ HealthBeat reports. Brownback said the 70th peer-reviewed publication showing a medical success from adult stem cells or stem cells from umbilical cord blood will be published this week, and he brought people who had received such treatments to speak at the conference. Brownback said it is important for umbilical cord blood to be stored and for adult stem cell treatment barriers to be lowered so that people do not have to travel outside of the U.S. to receive stem cell treatments. According to CQ HealthBeat, the press conference "countered" one recently held by senators who support embryonic stem cell research (Reichard, CQ HealthBeat, 6/20). Reps. Michael Castle (R-Del.) and Diana DeGette (D-Colo.) and Sens. Dianne Feinstein (D-Calif.), Tom Harkin (D-Iowa), Orrin Hatch (R-Utah), Edward Kennedy (D-Mass.), Gordon Smith (R-Ore.) and Arlen Specter (R-Pa.) last month participated in a conference organized by the Coalition for the Advancement of Medical Research calling on Senate Majority Leader Bill Frist (R-Tenn.) to bring to a vote a measure (HR 810, S 471) that would allow federal funding for research using stem cells derived from embryos originally created for fertility treatments and willingly donated by patients. Frist last month said he plans to schedule debate this summer on three separate bills involving stem cell research, but he did not stipulate which measures would be discussed. Other pending stem cell measures include a proposal (S 658) sponsored by Brownback that would prohibit human cloning for research and reproductive purposes, legislation (S 2754) introduced by Sens. Rick Santorum (R-Pa.) and Specter that would provide funding for NIH to research and create ways to retrieve pluripotent stem cells -- which, like embryonic stem cells, can produce all types of tissues in the body -- without destroying embryos; and a bill (S 1520) sponsored by Feinstein that would ban human cloning for reproductive purposes but not for therapeutic or research reasons (Kaiser Daily Women's Health Policy Report, 5/24).
Forum Participants Discuss Santorum, Specter Bill
In related news, advocates and opponents of embryonic stem cell research on Monday at a forum on Capitol Hill discussed the Santorum and Specter bill, CQ Healthbeat reports. Some researchers, such as Stanford University biochemist William Hurlbut, say that alternative methods to deriving pluripotent stem cells, such as altered nuclear transfer, also could advance the research without causing a moral debate, CQ HealthBeat reports (CQ HealthBeat, 6/19). Altered nuclear transfer involves implanting DNA from a donor's cell into a human egg that has had its nucleus removed and then stimulating the egg to divide. With this technique, scientists could prevent cells from organizing into a human embryo and still harvest embryonic stem cells, according to Hurlbut (Kaiser Daily Women's Health Policy Report, 2/14). However, W. Malcolm Byrnes, a Howard University College of Medicine biochemistry professor, and Catholic University of America professor Jose Granados in a paper wrote that altered nuclear transfer goes through stages that are "indistinguishable from those of a normal embryo," adding, "Could we not say, then, that we have created a defective embryo that is from the outset prevented from developing fully?" In addition, Paul Schenck, director of the National Pro-Life Action Center, said that a Senate vote to fund the measure would "set up a slippery slope and be morally bankrupt ... [and] would be an act of gross negligence." However, Richard Doerflinger, deputy director of the secretariat for pro-life activities at the United States Conference of Catholic Bishops, said the bill promotes only methods of deriving pluripotent stem cells that do not destroy a human embryo, and if a method such as altered nuclear transfer created a defective embryo, it would not be permitted under the measure (CQ HealthBeat, 6/19).